Ellen Vinge
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Neurology top 5%
- Intracranial Aneurysms: Treatment and Complications
- Traumatic Brain Injury and Neurovascular Disturbances
- Neurosurgical Procedures and Complications
- Vascular Malformations Diagnosis and Treatment
Papers in
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 5
- Inflammatory mediators and NSAID effects 5
- Pharmacogenetics and Drug Metabolism 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Co-authors
- Anders GrubbP. Nilsson–EhleKarl‐Erik AnderssonBirger LindergårdKent AnderssonTomas AnderssonMatthias StahlLennart Brandt
In The Last Decade
Ellen Vinge
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Nephrology 199
- Neurology 272
- Geriatrics and Gerontology 40
- Biological Psychiatry 24
- Psychiatry and Mental health 142
Countries citing papers authored by Ellen Vinge
This map shows the geographic impact of Ellen Vinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Vinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Vinge more than expected).
Fields of papers citing papers by Ellen Vinge
This network shows the impact of papers produced by Ellen Vinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Vinge. The network helps show where Ellen Vinge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ellen Vinge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 10 | |
| 2 | 2008 | 4 | |
| 3 | Glukosamin för lindring av besvär vid artros | 2005 | 0 |
| 4 | 2005 | 7 | |
| 5 | 1999 | 209 | |
| 6 | 1998 | 5 | |
| 7 | 1997 | 0 | |
| 8 | 1997 | 8 | |
| 9 | Pravidel kan ge lungförändringar. Aktivitetstecken och viktnedgång ingår i bilden | 1994 | 0 |
| 10 | 1993 | 5 | |
| 11 | 1993 | 15 | |
| 12 | 1992 | 8 | |
| 13 | 1991 | 6 | |
| 14 | 1990 | 29 | |
| 15 | 1990 | 47 | |
| 16 | 1989 | 23 | |
| 17 | 1988 | 6 | |
| 18 | 1988 | 10 | |
| 19 | 1988 | 4 | |
| 20 | 1988 | 20 |
About Ellen Vinge
Ellen Vinge is a scholar working on Pharmacology, Pharmacology, Cardiology and Cardiovascular Medicine, Anesthesiology and Pain Medicine and Applied Microbiology and Biotechnology, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Inflammatory mediators and NSAID effects (5 papers), Neurosurgical Procedures and Complications (4 papers), Intracranial Aneurysms: Treatment and Complications (4 papers), Analytical Methods in Pharmaceuticals (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Nephrology (199 citations), Neurology (272 citations), Geriatrics and Gerontology (40 citations), Biological Psychiatry (24 citations) and Psychiatry and Mental health (142 citations). Ellen Vinge has collaborated with scholars based in Sweden, Denmark and Germany. Frequent co-authors include Anders Grubb, P. Nilsson–Ehle, Karl‐Erik Andersson, Birger Lindergård, Kent Andersson, Tomas Andersson, Matthias Stahl, Lennart Brandt, Hans Säveland and Bengt Ljunggren. Their work appears in journals such as European Journal of Clinical Pharmacology, Journal of Cardiovascular Pharmacology, Therapeutic Drug Monitoring, Acta Anaesthesiologica Scandinavica and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.